One experiment looked at the relative amounts of mRNA using real-time RTq-PCR. All mRNA species were detectable, with cysQ being most abundant (approximately

the same level as sigA, the major housekeeping sigma factor), selleckchem and impA being the least abundant, with a level only one-tenth that of cysQ. We also assayed the level of IMPase activity in the whole cell extracts of each mutant, reasoning that we might see a decrease in activity when one of the genes was deleted. However, no decrease in activity was observed in any of the three mutants compared to the wild-type strain. This could be a reflection on the sensitivity of our assay, or could indicate that the activity is regulated (either at the transcriptional or post-transcriptional level) such that a constant level is maintained. We also have preliminary Palbociclib data that expression of the impC gene is regulatable. We grew a Δino1 mutant of M. tuberculosis (which needs >50 mM inositol for its normal growth [23]) and looked at the effect of removal of the inositol on gene expression. The only IMPase

gene with changed expression was impC, which was 3-fold increased. We cannot link this change directly to the inositol, because it could also be caused by the change in osmolarity, but at the very least indicates this indicates this gene is regulatable (unpublished results). The situation with impC is complicated in that we could neither obtain a mutant, nor do we have biochemical evidence that it functions as an IMPase (despite many attempts to achieve both). The essentiality cannot be a simple case of impC producing the majority of the inositol in the cell, as we added inositol exogenously. It is true that the ino1 mutant we made previously, which is an inositol auxotroph, required 4-Aminobutyrate aminotransferase levels of inositol approaching the maximum solubility limit, so a requirement for a slightly increased level of inositol might explain our

findings. However, this is unlikely because (i) we also introduced a porin gene to increase inositol uptake, with no effect, (ii) we would also have to explain why the other three IMPase genes are not sufficient, and (iii) the level of impC mRNA is only 21% of the total IMPase mRNA (41% if cysQ is excluded). The only pieces of evidence we have, therefore, that link impC to inositol production are (i) its clear homology to IMPases, and (ii) the circumstantial evidence that levels of impC increased in a microarray experiment where inositol was removed from an ino1 auxotroph, whereas the expression level of the other IMPase genes was not significantly changed. We recognise the difficulty of carrying out the latter experiment in a controlled way since removing such a high level of inositol from the medium could have other effects. Interestingly, impC was also upregulated in the Wayne low oxygen model, particularly when M.

J Gen Microbiol 1991, 137: 1511–1522.PubMed 37. Kleiner D, Paul W, Merrick MJ: Construction of Multicopy Expression

Vectors for Regulated over-Production of Proteins in Klebsiella pneumoniae and Other Enteric Bacteria. J Gen Microbiol 1988, 134: 1779–1784.PubMed 38. Souza EM, Pedrosa FO, Rigo LU, Machado HB, Yates MG: Expression of the nifA gene of Herbaspirillum seropedicae : role of the NtrC and NifA binding sites and of the-24/-12 promoter element. Microbiology-Sgm 2000, 146: 1407–1418. 39. Simon R, Priefer U, Puhler A: A Broad Host Range Mobilization System for Invivo Genetic-Engineering Selleckchem RXDX-106 – Transposon Mutagenesis in Gram-Negative Bacteria. Bio-Technology 1983, 1 (9) : 784–791. 40. Souza EM, Funayama S, Rigo LU, Pedrosa FO: Cloning and Characterization of the nifA gene from Herbaspirillum seropedicae Strain Z78. Can J Microbiol 1991, 37 (6) : 425–429.PubMedCrossRef 41. Woodley P, Buck M, Kennedy C: Identification of sequences important for recognition of vnf genes by the VnfA transcriptional activator in Azotobacter vinelandii . FEMS Microbiol Lett 1996, 135 (2–3) : 213–221.PubMedCrossRef 42. Mead DA, Szczesna-Skorupa E, Kemper B: Single-stranded DNA ‘blue’ T7 promoter

plasmids: a versatile tandem promoter system for cloning and protein engineering. Protein Eng 1986, 1 (1) : 67–74.PubMedCrossRef Authors’ contributions LN constructed plasmids and H. seropedicae mutants, carried out physiological experiments and helped to draft the manuscript; ACB constructed plasmids and carried out immunoassays; RAM constructed plasmids and designed some of the experiments; LN, RAM and LUR helped to draft the manuscript; selleck compound FOP, EMS, MBRS and LSC conceived the study, participated in its design and in writing

the manuscript, LSC also supervised the study. All authors read and approved the final manuscript.”
“Background A substantial amount of the genetic variation in bacteria is carried in plasmids [1]. Plasmids are part of the flexible genome, which is defined by the high plasticity and modularity of its genetic elements and high rates of gene acquisition and loss [2]. They are typically composed of conserved backbone modules coding for replication, Integrase inhibitor maintenance and transfer functions as well as variable accessory modules. The capture of genetic modules by plasmid backbones can increase phenotypic diversity and thereby increase the chances of responding to uncertain environmental changes or of exploiting an opportunity for transient niche expansion [2, 3]. Plasmids are classified according to incompatibility (Inc) groups that are based on the inability of plasmids with the same replication or segregation mechanisms to co-exist in the same cell [4]. IncA/C plasmids have attracted the attention of the research community due to their ability to acquire antimicrobial resistance traits and to mobilize them across geographical and taxonomical borders [5].

I. Franke for her assistance with the English transcript. References 1. Boone JM: Radiological interpretation 2020: Toward quantitative image assessment. Med Phys 2007, 34: 4173–4179.CrossRefPubMed 2. Roberts HC, Roberts TPL, Lee TY, Dillon WP: Dynamic, Contrast-Enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow, and microvascular permeability: Report of two cases. AJNR 2002, 23: 828–832.PubMed 3. Di Nallo AM, Crecco M, Ortenzia O, Ordonez R, Abate A, Benassi M: The breast dynamic see more contrast enhanced MRI: Preliminary results of a quantitative analysis. J Exp Clin Cancer Res 2007, 26: 235–239.PubMed 4. Miles KA, Griffiths MR: Perfusion CT: a worthwhile

enhancement? Br J Radiol 2003, 76: 220–31.CrossRefPubMed 5. Hoeffner EG, Case I, Jain R, Gujar SK, Shah GV, Deveikis JP, Carlos RP, Thompson BG, Harrigan MR, Mukherji SK: Cerebral Perfusion CT: Technique and Clinical applications. Radiology 2004, 231: 632–644.CrossRefPubMed 6. Eastwood JD, Provenzale JM: Cerebral blood flow, blood volume and vascular permeability of cerebral glioma assessed with dynamic CT perfusion GSK-3 assay imaging. Neuroradiology 2003, 45: 373–376.CrossRefPubMed 7. Ding B, Ling HW, Chen KM,

Jiang H, Zhu YB: Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging. Neuroradiology 2006, 48: 773–781.CrossRefPubMed 8. Jain R, Ellika SK, Scarpace L, Schultz LR, Rock JP, Gutierrez J, Patel J, Ewing SC, Mikkelsen T: Quantitative Estimation of Permeability Surface-Area Product in Astroglial Brain Tumors Using Perfusion CT and Correlation with Histopathologic Grade. AJNR 2008, 29: 694–700.CrossRefPubMed 9. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY: A CT Method to Measure Hemodynamics in Brain Tumors: Validation and Application of Cerebral Blood Flow Maps. AJNR 2000, 21: 462–470.PubMed Ureohydrolase 10. Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W: Regional Blood Flow, Capillary Permeability, and Compartmental Volumes: Measurement with Dynamic CT – Initial Experience. Radiology 1999, 210: 269–276.PubMed 11. Sahani DV, Kalva SP, Hamberg

LM, Hahn PF, Willett CG, Saini S, Mueller PR, Lee T: Assessing Tumor Perfusion and Treatment Response in Rectal Cancer with Multisection CT: Initial Observations. Radiology 2005, 234: 785–792.CrossRefPubMed 12. Molen AJ, Veldkamp WJH, Geleijns J: 16-slice CT: achievable effective doses of common protocols in comparison with recent CT dose surveys. British Journal of Radiology 2007, 80: 248–255.CrossRefPubMed 13. Axel L: Cerebral blood flow determination by rapid-sequence computed tomography. Radiology 1980, 137: 679–686.PubMed 14. Patlak CS, Blasberg RG: Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985, 5: 584–590.PubMed 15. Metz CE: Some practical issues of experimental design and data analysis in radiological ROC studies.

3 Ordinal (current, past, never) 0.62 0.34, 0.90 Other medications  Hormone replacement therapy  Current 71 8.3 57 6.6 Dichotomous (current or not) 0.75 0.66, 0.83  Past 265 30.9 47 5.5 Dichotomous (ever or never) 0.33 0.28, 0.39  Never 521 60.8 754 87.9 Selleckchem Doramapimod Ordinal (current, past, never) 0.44 0.38, 0.50  Oral steroids  Current 19 2.2 18 2.1 Dichotomous (current or not) 0.59 0.40, 0.78

 Past 82 9.6 18 2.1 Dichotomous (ever or never) 0.35 0.25, 0.46  Never 756 88.2 822 95.8 Ordinal (current, past, never) 0.41 0.30, 0.51  Thyroid medication (e.g., Synthroid® or Eltroxin®)  Current 155 18.1 169 19.7 Dichotomous (current or not) 0.92 0.88, 0.95  Past 30 3.5 –e –e Dichotomous (ever or never) 0.86 0.81, 0.90  Never 672 78.4 686 80.0 Ordinal (current, past, never) 0.88 0.85, 0.92

aEver in lifetime, see “Appendix” for LY2157299 in vivo question wording bAny use within 365 days prior to questionnaire completion; current use was identified by drug coverage at the time of questionnaire completion, defined by the most recent prescription dispensing date prior to the questionnaire date plus days supplied and 50% of days supplied grace period cDichotomous: kappa statistic; ordinal: quadratic weighted kappa statistic dQuadratic weighted kappa statistic for any osteoporosis pharmacotherapy (bisphosphonate, calcitonin, and raloxifene) = 0.81, 95% CI = 0.76, 0.86 eNumbers suppressed due to small cell sizes (<5) Validity of claims data to identify DXA testing Physicians confirmed the presence of a DXA test in 379 women. The sensitivity of claims data to identify these 379 confirmed DXA tests was 98% (95% CI = 95.9, 99.1; Table 3). Using self-report of DXA testing as the gold standard, the estimated specificity of a reimbursement claim for DXA testing was 93% (95%CI = 89.8, 95.4). Table 3 Proportion of women with a dual-energy X-ray absorptiometry (DXA) test identified in claims data among those reporting to have had a DXA test, by length of claims lookback period, N = 501   Percent

with DXA identified using medical services claims data,a lookback period 1 year 2 years 3 years 5 years From 1991c DXA confirmed by physician, n = 379 35.9 60.7 75.2 90.0 97.9 DXA not confirmed by physician, n = 27 0.0 7.4 11.1 18.5 29.6 Missing,b n = 95 25.3 47.4 64.2 74.7 87.4 Five hundred one of 858 participants reported having ever had DXA test during the standardized telephone Montelukast Sodium interview aOHIP fee code, any of J654, J655, J656, J688, J854, J855, J856, J888, X145, X146, X149, X152, X153, X155, and X157 bPatient self-report yes, but either did not receive written permission to obtain the result or did not receive a physician response to our request for information regarding DXA testing cJuly 1991 is when individual data were first available, i.e., as far back as healthcare utilization data capture Validity of claims data to identify DXA-documented osteoporosis Of the 379 confirmed DXA tests, we obtained 359 complete DXA reports, and 114 (32%) had DXA-documented osteoporosis.

4813605CrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions CFD and CHL carried out the characterizations of the device and PL measurements and participated in data interpretation. CTC performed the Raman spectra measurement. KHL synthesized the ZnO microstructures. JKS provided the GaN thin films and participated in data interpretation. HCH initiated the study, designed all the experiments, and analyzed the data. CFD and HCH wrote the manuscript. All authors read and approved the final version of the manuscript.”
“Background

Because of their excellent mechanical, electrical, and thermal properties, carbon nanotubes (CNTs) have been used in many areas such as conductive or electromagnetic devices, sensors, high-strength composites, and multifunctional Decitabine cost membranes [1–4]. Single-walled carbon nanotubes (SWCNTs) or multi-walled carbon nanotubes (MWCNTs) which have atomically smooth inner surfaces could provide us with ideal systems

for the investigation on the characteristics of molecular transport in the nanometer scales [5, 6]. Recently, the phenomena of gas transport through CNTs embedded in polymer matrix are of great interest. The low-cost CNT/polymer composites are promising membranes which possess high transparency and extraordinary gas permeance performance [7, 8]. CNT-based membranes https://www.selleckchem.com/products/Nutlin-3.html Sorafenib mw have opened up a new prospect for the selective separation of gases [9, 10]. CNTs exhibit routes of fast interfacial slip for gas molecules on their inner walls since they have a large non-interacting van der Waals distance and atomically smooth surfaces that do not scatter gas molecules. In addition, CNTs may provide uniform pore structures at the nanometer scales that can be finely tailored by controlling the catalyst particle sizes. Polymer matrix membranes with CNTs as fillers have attracted great attention

since they are resilient, easily fabricated, and chemically stable. Unfortunately, random aggregations and dispersions of CNTs in the polymer matrix are usually found in the CNT/polymer membranes fabricated by a conventional solution method, which deteriorate the gas permeance performances of the membranes [11, 12]. In order to synthesize high-performance membranes, a lot of efforts have been devoted to improve CNT alignments with the assistances of electrical fields, flowing gases, and surface-lattice-guided growth of CNTs or CNT sheets [13, 14]. However, it remains a challenge to fabricate composite membranes in which good CNT alignment and high porosity were achieved simultaneously for high gas permeance. To address these issues, a fabrication method was developed by infiltrating vertically aligned CNTs (VACNTs) with poly-para-xylylene (parylene-C) through a vapor deposition technique [15–18].

However, during short bursts of intense exercise, such as HIIT, physico-chemical buffering will exceed that by HCO3 – mediated dynamic buffering, calling on intramuscular stores of phosphates and peptides. Specifically, carnosine (β-alanyl-L-histidine), a cytoplasmic dipeptide, constitutes an important non-bicarbonate physico-chemical buffer. By virtue of a pKa of 6.83 and its high concentration in muscle, carnosine is more effective at sequestering protons

than either bicarbonate (pKa 6.37) or inorganic selleckchem phosphate (pKa 7.2), the other two major physico-chemical buffers over the physiological pH range [7, 13]. However, as a result of the greater concentration of carnosine in muscle than bicarbonate in the initial stages of muscle contraction, and inorganic phosphate, its buffering contribution may be quantitatively more important. Mechanisms for increasing muscle carnosine concentration have been somewhat disputed. While carnosine may be increased in chronically trained athletes, the effects of acute training are less clear. In

one study, it has been reported that eight weeks of intensive training may increase intramuscular carnosine content [14]. In contrast, several other studies have shown that intense training, of up to 16 weeks, has been unable to promote a rise in skeletal muscle carnosine levels [6, 15–17]. Only when β-alanine supplementation was combined with training did an increase in muscle carnosine occur [16], although the increase (40–60%) was similar to that seen with supplementation alone [18]. While carnosine is synthesized in the muscle from its two constituents, β-alanine and histidine [19], synthesis Raf activity is limited by the availability of β-alanine [18, 20]. β-alanine supplementation alone has been shown to significantly increase Thiamet G the intramuscular carnosine content [6, 18]. Elevation of intramuscular carnosine content via β-alanine supplementation alone, has been shown to improve performance [6, 14, 21–24]. Recently, Hill and colleagues [6] demonstrated

a 13% improvement in total work done (TWD) following four weeks of β-alanine supplementation, and an additional 3.2% increase after 10 weeks. Zoeller et al. [24] also reported significant increases in ventilatory threshold (VT) in a sample of untrained men after supplementing with β-alanine (3.2 g·d-1) for 28 days. In agreement, Kim et al. [21] also reported significant increases in VT and time to exhaustion (TTE) in highly trained male cyclists after 12 weeks of β-alanine (4.8 g·d-1) supplementation and endurance training. Furthermore, Stout et al. [22, 23] reported a significant delay in neuromuscular fatigue, measured by physical working capacity at the fatigue threshold (PWCFT), in both men and women after 28 days of β-alanine supplementation (3.2 g·d-1 – 6.4 g·d-1). Despite the improvements in VT, TTE, TWD, and PWCFT after supplementation, there were no increases in aerobic power, measured by VO2peak [22–24].

Similarly, it has been reported that dogs leaving the veterinary intensive care unit (ICU) carry a very large multi-drug resistant enterococcal

population with capacity for horizontal gene transfer [63]. As a consequence, the authors recommended restriction of close physical contact between pets released from ICUs and their owners to avoid potential health risks [63]. Conclusions Milk from different mammalian EGFR inhibitor review species may contain enterococci. The wide distribution of virulence genes and/or antibiotic resistance among E. faecalis and E. faecium strains isolated from such source indicates that they can constitute a reservoir of such traits for the infant/offspring gut and, as a consequence,

a potential risk to animal and human health. In fact, some STs detected among E. faecalis strains isolated from porcine or feline samples in this study belong to clonal complexes (CC16 and CC21) frequently associated to hospital infections in Europe. Acknowledgements This study was supported by the CSD2007-00063 (FUN-C-FOOD, Consolider-Ingenio 2010), AGL2010-18430, AGL2010-15420 and SAF2012-35474 projects from the Ministerio ALK inhibitor de Economía y Competitividad (Spain). References 1. Butler JE: Immunoglobulins and immunocytes in animal milks. In Mucosal Immunology. Edited by: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR. New York: Academic Press; 1999. 2. Kehrli ME Jr, Harp JA: Immunity in the mammary gland. Vet Clin North Am Food Anim Pract 2001, 17:495–516.PubMed 3. Newburg DS, Walker

WA: Protection 6-phosphogluconolactonase of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 2007, 61:2–8.PubMedCrossRef 4. Stelwagen K, Carpenter E, Haigh B, Hodgkinson A, Wheeler TT: Immune components of bovine colostrum and milk. J Anim Sci 2009,87(Suppl 13):3–9.PubMed 5. Hurley WL, Theil PK: Perspectives on immunoglobulins in colostrum and milk. Nutrients 2011, 3:442–474.PubMedCentralPubMedCrossRef 6. Heikkilä MP, Saris PEJ: Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J Appl Microbiol 2003, 95:471–478.PubMedCrossRef 7. Martín R, Langa S, Reviriego C, Jiménez E, Marín ML, Xaus J, Fernández L, Rodríguez JM: Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 2003, 143:754–758.PubMedCrossRef 8. Martín R, Delgado S, Maldonado A, Jiménez E, Olivares M, Fernández L, Sobrino OJ, Rodríguez JM: Isolation of lactobacilli from sow milk and evaluation of their probiotic potential. J Dairy Res 2009, 76:418–425.PubMedCrossRef 9. Martín R, Olivares M, Pérez M, Xaus J, Torre C, Fernández L, Rodríguez JM: Identification and evaluation of the probiotic potential of lactobacilli isolated from canine milk. Vet J 2010, 185:193–198.PubMedCrossRef 10.

For western

blots, samples were transferred to PVDF membranes, blocked in 2% BSA 1X TBS-T, followed by addition of primary antibodies (SantaCruz Biotechnology and Millipore) and detected via chemiluminescence (Amersham). Transfection and RhoA Constructs RhoA DNA constructs, (kind gifts of Ian Whitehead), Kinase Inhibitor Library manufacturer were grown as described [31]. Briefly, cDNAs encoding human wild-type RhoA, fused to an NH2-terminal hemagluttinin (HA)-epitope tag were generated and cloned into pAX142. An identical mutant panel was generated for each isoform: RhoA-19N (dominant-inhibitory), RhoAWT (wild type), and RhoA-63L (constitutively active) [32]. DNA was isolated from bacterial cultures using Highspeed Plasmid MAXI Kit, (Qiagen) according to the manufacturer’s instructions. RhoA constructs were transfected using Fugene6 transfection reagent (Roche) according to the manufacturer’s instructions into MCF-7 cells cultured at clonogenic density on FN coated coverslips. Rho constructs were co-transfected with pmaxGFP DNA (AMAXA) at previously

optimized concentrations for maximum transfection efficiency at ratios of 10:1 or 3.0 μg RhoA constructs/0.3 μg GFP Sorafenib solubility dmso vector DNA. Medium was replenished at 12 h, and FGF-2 10 ng/ml was added on day 2 after transfection. Cells were stained with rhodamine phalloidin on day 4 following transfection, as described above. Cells were counted as having cortical actin rearrangement when >50% of

the cell’s periphery was subtended by cortical actin. GFP positive cells in dormant clones (consisting of < 12 cells) or in growing clones (> 30 cells) were used for quantitation. Tryptophan synthase Triplicate cover slips were independently transfected in two separate experiments. Means and standard deviations for data collected from green fluorescent cells on the three slides were calculated in each experiment and the significance of differences between different vector transfections were determined using Student’s t test. Cell Fractionation The Qiagen Qproteome Cell Compartment fractionation kit (Qiagen) was used to isolate plasma membranes and cytoplasmic fractions from cells in dormant or growing clones according to the manufacturer’s protocol. Briefly, equal numbers of cells from dormant (+FGF-2) or growing (-FGF-2) clones cultured on FN-coated plates were subjected to sequential centrifugation during which soluble fractions containing plasma membrane and cytosolic fractions were extracted. Fractions were subjected to SDS PAGE and immunoblotted with anti-GRAF goat polyclonal antibody (Santa Cruz Biotechnology) and anti-BAX antibody as a localization control.

We monitored beneficial (SCFA and lactate) and putrefactive/toxic (BCFA and ammonia) metabolites. The intestinal microbiota composition https://www.selleckchem.com/products/sotrastaurin-aeb071.html was also analyzed under the different conditions. Methods Test products The two test products were Clindamycin and VSL #3. Clindamycin (Fresenius Kabi, Bad Homburg, Germany) is a broad-spectrum lincosamide antibiotic usually used to treat anaerobic infections. It is effective against most Gram-positive cocci and Gram-negative anaerobic bacteria

and comparable with macrolide antibiotics. VSL#3 (Sigma-tau, Duesseldorf, Germany) is a multi-species probiotic and contains the following 8 species: Streptococcus thermophilus, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei and Lactobacillus delbrueckii subsp. bulgaricus. Ethical approval A general ethical committee vote for the collection of PF-02341066 mouse stool samples of healthy volunteers had been obtained from the local ethical board of the Medical Faculty of the Christian-Albrechts-University (CAU) in Kiel. All volunteers have given informed consent. Test system: TNO large-intestinal model

(TIM-2) The study was performed in the TNO dynamic system of the large intestine (TIM-2) as schematically represented in Figure 1 and as described in detail by Venema et al. [20] and Minekus et al. [17]. Figure Immune system 1 Schematic representation of the TNO TIM-2 in vitro model with (a) peristaltic compartments containing fecal matter; (b) pH electrode; (c) alkali pump; (d) dialysis liquid circuit with hollow fibre membrane;

(e) level sensor; (f) N 2 gas inlet; (g) sampling port; (h) gas outlet; (i) ‘ileal efflux’ container containing SIEM; (j) temperature sensor. In brief, the model consists of four glass units with a flexible wall inside (peristaltic compartments) and a total volume of 135 ml. Water of body temperature (37°C) was pumped into the space between the glass jacket and the flexible wall, causing the microbiota to be mixed and moved. The sequential squeezing of the walls, controlled by a computer, caused a peristaltic wave forcing the material to circulate through the loop-shaped system. Physiological electrolyte and metabolite concentrations in the lumen were maintained with a dialysis system consisting of hollow fibres, running through the lumen of the reactor, through which dialysis liquid was pumped at a speed of 1.5 ml/min. The model further contained an inlet system for delivery of the artificial ileal delivery medium (SIEM), and a level sensor to maintain the luminal content at the set level of 135 ml. The system was kept anaerobic by flushing with gaseous nitrogen. At the start of each experiment the model was inoculated with 30 ml of the standard, cultivated faecal microbiota, consisting of a mix of fecal samples from 7 individuals.

Proc Natl Acad Sci USA 1989,86(16):6383–6387.PubMedCrossRef

2. Lundberg U, Vinatzer U, Berdnik D, von Gabain A, Baccarini M: Growth phase-regulated induction of Salmonella -induced macrophage apoptosis correlates with transient expression of SPI-1 genes. J Bacteriol 1999,181(11):3433–3437.PubMed 3. Shea JE, Hensel M, Gleeson C, Holden DW: Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium . Proc Natl selleck chemicals Acad Sci USA 1996,93(6):2593–2597.PubMedCrossRef 4. Ochman H, Soncini FC, Solomon F, Groisman EA: Identification of a pathogenicity island required for Salmonella survival in host cells. Proc Natl Acad Sci USA 1996,93(15):7800–7804.PubMedCrossRef 5. Steele-Mortimer O, Brumell JH, Knodler LA, Meresse S, Lopez A, Finlay BB: The invasion-associated type III secretion system of Salmonella enterica serovar Typhimurium is necessary for intracellular proliferation and vacuole biogenesis

in epithelial cells. Cell Microbiol 2002,4(1):43–54.PubMedCrossRef 6. Beuzon CR, Banks G, Deiwick J, Hensel 5-Fluoracil cost M, Holden DW: pH-dependent secretion of SseB, a product of the SPI-2 type III secretion system of Salmonella typhimurium . Mol Microbiol 1999,33(4):806–816.PubMedCrossRef 7. Bijlsma JJ, Groisman EA: The PhoP/PhoQ system controls the intramacrophage type three secretion system of Salmonella enterica . Mol Microbiol 2005,57(1):85–96.PubMedCrossRef 8. Lee AK, Detweiler the CS, Falkow S: OmpR regulates the two-component system SsrA-ssrB in Salmonella pathogenicity island 2. J Bacteriol 2000,182(3):771–781.PubMedCrossRef 9. Linehan SA, Rytkonen A, Yu XJ, Liu M, Holden DW: SlyA regulates function of Salmonella pathogenicity island 2 (SPI-2) and expression of SPI-2-associated genes. Infect Immun 2005,73(7):4354–4362.PubMedCrossRef 10. Navarre WW, Halsey TA, Walthers D, Frye J, McClelland M, Potter JL, Kenney LJ, Gunn JS, Fang FC, Libby SJ: Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial

peptides by SlyA and PhoP/PhoQ. Mol Microbiol 2005,56(2):492–508.PubMedCrossRef 11. Okada N, Oi Y, Takeda-Shitaka M, Kanou K, Umeyama H, Haneda T, Miki T, Hosoya S, Danbara H: Identification of amino acid residues of Salmonella SlyA that are critical for transcriptional regulation. Microbiology 2007,153(Pt 2):548–560.PubMedCrossRef 12. Pizarro-Cerda J, Tedin K: The bacterial signal molecule, ppGpp, regulates Salmonella virulence gene expression. Mol Microbiol 2004,52(6):1827–1844.PubMedCrossRef 13. Song M, Kim HJ, Kim EY, Shin M, Lee HC, Hong Y, Rhee JH, Yoon H, Ryu S, Lim S, et al: ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. J Biol Chem 2004,279(33):34183–34190.PubMedCrossRef 14.